Prostate cancer is a common disease among men, with one in eight being diagnosed with it during their lifetime, as reported by the American Cancer Society. The treatment approach for prostate cancer depends on the risk of locally advanced or metastatic disease. In cases where the cancer is low-risk and unlikely to spread quickly, active surveillance is often recommended.
Active surveillance involves closely monitoring the individual for any signs of cancer progression through regular PSA blood tests, digital rectal exams, and prostate biopsies guided by MRI imaging. The frequency of these tests varies based on the individual’s risk factors.
Dr. Jeffrey Tomasini, a urologic surgeon at Aurora Health Care, explains that active surveillance is ideal for men with low-risk prostate cancer as it allows them to avoid immediate surgery or radiation treatment. However, if the cancer progresses to intermediate or high-risk levels during surveillance, active treatment may be recommended.
Prostate cancer often does not show symptoms in its early stages, making early detection crucial for successful treatment. Once symptoms like unexplained weight loss, bone pain, or urinary issues appear, the chances of a cure diminish.
According to Dr. Tomasini, early identification of prostate cancer is key to achieving a favorable outcome. Men aged 55 to 69 are advised to discuss prostate cancer screening with their healthcare provider.
Are you seeking a cancer expert? Explore options in Illinois or Wisconsin for specialized cancer care.